MAI Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-585
Closed -$59.4K 5063
2025
Q4
$59.4K Sell
585
-447
-43% -$35.9K ﹤0.01% 1912
2025
Q3
$56.5K Sell
1,032
-259
-20% -$12.9K ﹤0.01% 1855
2025
Q2
$68.6K Sell
1,291
-149
-10% -$7.57K ﹤0.01% 1675
2025
Q1
$62.3K Sell
1,440
-2
-0.1% -$101 ﹤0.01% 1632
2024
Q4
$81K Buy
+1,442
New +$89.7K ﹤0.01% 1535
2021
Q4
Sell
-2,235
Closed -$213K 942
2021
Q3
$213K Buy
2,235
+324
+17% +$34.2K ﹤0.01% 712
2021
Q2
$238K Buy
1,911
+11
+0.6% +$1.31K ﹤0.01% 663
2021
Q1
$250K Buy
+1,900
New +$260K 0.01% 621
2018
Q4
Sell
-1,500
Closed -$118K 462
2018
Q3
$118K Buy
+1,500
New +$97.8K 0.01% 464

Other funds holding EXAS

MAI Capital Management's EXAS Position: Q1 2026 in Review

MAI Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 585 shares — an estimated $59.4K sold.

MAI Capital Management first reported a position in EXAS in Q3 2018 and held it in 9 quarters. The position peaked at $250K in Q1 2021. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • MAI Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • MAI Capital Management sold 585 Exact Sciences shares in Q1 2026, an estimated $59.4K.
  • MAI Capital Management first reported a position in Exact Sciences in Q3 2018 and held it in 9 quarters.
  • MAI Capital Management's Exact Sciences position peaked at $250K in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.